LUND, Sweden, 27 April 2018 /PRNewswire/ --NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) ("NeuroVive") today on 27 April 2018 held its Annual General Meeting (AGM). A summary of the resolutions follows. All resolutions were passed with the required majority. Appro...
from PR Newswire: //https://ift.tt/2HzXon8
No comments:
Post a Comment